Citation Impact

4 from Science/Nature 61 standout
Sub-graph 1 of 24

Citing Papers

Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
Fibroblasts in cancer: Unity in heterogeneity
2023 Standout
2 intermediate papers

Works of Peter Onody being referenced

Prognostic value ofERBBfamily mRNA expression in breast carcinomas
2003

Author Peers

Author APM CCICM Developmental Neuroscience Molecular Biology Oncology Last Decade Papers Cites
Peter Onody 186 56 85 239 239 17 777
Hongjie Yu 9 419
Mira Heinonen 1 443 235 9 625
Yang‐Chyuan Chang 14 18 9 54 20 19 782
Akira Kira 183 52 90 1.5k
Cuiping Wang 2 15 711

All Works

Loading papers...

Rankless by CCL
2026